Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463171 | 12546317 | 1 | I | 20160702 | 20160704 | 20160711 | 20160711 | EXP | PHHY2016CN092319 | NOVARTIS | 73.00 | YR | M | Y | 51.00000 | KG | 20160711 | MD | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463171 | 12546317 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous drip | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
125463171 | 12546317 | 2 | C | HEPARIN CALCIUM | HEPARIN CALCIUM | 1 | Subcutaneous | 5000 IU, QD | 55000 | IU | Y | 0 | 5000 | IU | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125463171 | 12546317 | 1 | Osteoporosis |
125463171 | 12546317 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125463171 | 12546317 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125463171 | 12546317 | Cerebral infarction | |
125463171 | 12546317 | Coma | |
125463171 | 12546317 | Loss of consciousness | |
125463171 | 12546317 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125463171 | 12546317 | 1 | 20160701 | 0 | ||
125463171 | 12546317 | 2 | 20160622 | 20160704 | 0 |